In a 2011 retrospective study, Jayasena and colleagues found that patients with prolonged exposure to elevated IGF-1 and GH levels were more likely to have diagnoses of impaired glucose tolerance, cardiovascular system disorders, and diabetes compared to those with a lesser cumulative biochemical burden [17]. Here, GH1 is linked to cardiovascular disorder.